When treating septic shock, a synergistic approach of early multimodal use of vasopressors and adjuncts is preferable to high doses of a single vasopressor and waiting for its likely failure, according to a review (Ann Intensive Care 2022;12[1]:47).
“We felt we needed to offer additional information beyond the surviving sepsis guidelines, so critical care providers can make informed decisions on when to use vasopressors and resuscitative fluid for managing septic shock, as well as